Skip to content

Workability, Health Literacy and Quality of Life of Patients with Common Variable Immunodeficiency Syndrome - Study Phase II

Workability, Health Literacy and Quality of Life of Patients with Common Variable Immunodeficiency Syndrome - Study Phase II - WoHL-CVID II

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00012336
Enrollment
120
Registered
2017-04-24
Start date
2017-04-24
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

D83

Interventions

Group 1: Patients with CVID who are interested in the offered training receive a 2.5-hour communication training to improve their health literacy. Subjects are active communication about the disease w

Sponsors

Centrum für Chronische Immundefizienz (CCI)am Zentrum für Translationale Zellforschung (ZTZ)Clinical Research Unit
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: CVID Patients who have been treated in the Center for Chronic Immunodeficiency (CCI) in Freiburg since January 1, 2012/ Patient consent declaration/ Participation in the first study phase WoHL-CVID I

Exclusion criteria

Exclusion criteria: Patient with a very high disease burden and a short life expectancy or a permanently very bad general health condition. Not enough knowledge of the German language in spoken and written, strong cognitive restrictions.

Design outcomes

Primary

MeasureTime frame
Evaluation of the effectiveness of the training developed in the first study phase.The primary endpoint is the change of the patient reported outcome "Health education literacy of patients" (HELP) between baseline (T0) and after four months (T1).

Secondary

MeasureTime frame
1. Assessment of the satisfaction of the participants with the training. 2. Identify groups that are particularly benefiting by the training.

Countries

Germany

Contacts

Public ContactAlexandra Nieters

Centrum für Chronische Immundefizienz (CCI)am Zentrum für Translationale Zellforschung (ZTZ)Clinical Research Unit

alexandra.nieters@uniklinik-freiburg.de+49 761 270-78150

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026